Is EDNSF or MRK a better dividend investment in 2026?

EDNSF currently yields 5714.29% with a 5% 5-year dividend growth rate. MRK yields 2.76% with 8.2% growth. The better choice depends on your goal: EDNSF offers higher current income.

What is the dividend yield difference between EDNSF and MRK?

EDNSF has a forward dividend yield of 5714.29% ($2.00/share annually). MRK yields 2.76% ($3.32/share annually). The yield gap is 5711.53 percentage points.

Home › Compare › EDNSF vs MRK

EDNSF vs MRK: Dividend Comparison 2026

EDNSF yields 5714.29% · MRK yields 2.76%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 EDNSF wins by $228153224412509.53M in total portfolio value

INVESTMENT

TIME HORIZON10 years

EDNSF

● Live price

5714.29%

Share price

$0.04

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$228153224412509.59M

Annual income

$220,560,399,839,122,060,000.00

Full EDNSF calculator →

MRK

Merck & Co. Inc.

● Live price

2.76%

Share price

$120.31

Annual div

$3.32

5Y div CAGR

32.7%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$56.8K

Annual income

$9,798.13

Full MRK calculator →

Portfolio growth — EDNSF vs MRK

📍 EDNSF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	EDNSF	MRK
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, EDNSF + MRK cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

EDNSF pays

MRK pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

EDNSF

Annual income on $10K today (after 15% tax)

$485,714.29/yr

After 10yr DRIP, annual income (after tax)

$187,476,339,863,253,750,000.00/yr

MRK

Annual income on $10K today (after 15% tax)

$234.56/yr

After 10yr DRIP, annual income (after tax)

$8,328.41/yr

At 15% tax rate, EDNSF beats the other by $187,476,339,863,253,750,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of EDNSF + MRK for your $10,000?

EDNSF: 50%MRK: 50%

100% MRK50/50100% EDNSF

Portfolio after 10yr

$114076612206254.83M

Annual income

$110,280,199,919,561,030,000.00/yr

Blended yield

96.67%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

EDNSF

No analyst data

Altman Z

2.2

Piotroski

4/9

MRK

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$128.54

+6.8% upside vs current

Range: $100.00 — $150.00

Altman Z

4.0

Piotroski

6/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

EDNSF buys

MRK buys

No recent congressional trades found for EDNSF or MRK in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricEDNSFMRK

Forward yield	5714.29% ✓	2.76%
Annual dividend / share	$2.00	$3.32 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	32.7% ✓
Portfolio after 10y	$228153224412509.59M ✓	$56.8K
Annual income after 10y	$220,560,399,839,122,060,000.00 ✓	$9,798.13
Total dividends collected	$227641622319776.13M ✓	$28.9K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: EDNSF vs MRK ($10,000, DRIP)

Year	EDNSF Portfolio	EDNSF Income/yr	MRK Portfolio	MRK Income/yr	Gap
1← crossover	$582,129	$571,428.57	$11,206	$366.19	+$570.9K → EDNSF
2	$31,711,186	$31,088,308.22	$12,650	$502.35	+$31.70M → EDNSF
3	$1,616,661,128	$1,582,730,159.44	$14,407	$694.19	+$1616.65M → EDNSF
4	$77,139,944,357	$75,410,116,950.20	$16,585	$967.82	+$77139.93M → EDNSF
5	$3,445,379,409,484	$3,362,839,669,021.90	$19,342	$1,363.89	+$3445379.39M → EDNSF
6	$144,058,436,084,716	$140,371,880,116,567.28	$22,913	$1,947.19	+$144058436.06M → EDNSF
7	$5,639,412,164,337,400	$5,485,269,637,726,755.00	$27,662	$2,823.89	+$5639412164.31M → EDNSF
8	$206,716,597,857,094,600	$200,682,426,841,253,570.00	$34,159	$4,173.35	+$206716597857.06M → EDNSF
9	$7,096,097,732,137,874,000	$6,874,910,972,430,782,000.00	$43,337	$6,308.80	+$7096097732137.83M → EDNSF
10	$228,153,224,412,509,600,000	$220,560,399,839,122,060,000.00	$56,776	$9,798.13	+$228153224412509.53M → EDNSF

EDNSF vs MRK: Complete Analysis 2026

EDNSF — Stock

Eden Research plc offers sustainable solutions for crop protection, animal health, and consumer products in the United Kingdom and rest of Europe. The company provides crop protection products for foliar disease and insect control, open field and greenhouses, soil pests, post-harvest shelf-life extension, and seed treatment applications. It also offers animal health products, such as companion animal, bio-control, parasite treatments, and insect spray products. In addition, the company provides human health products comprising head-lice treatment products, fragrances, deodorants, wound-care products, food flavorings, odor neutralizers, and active ingredient supply/delivery products. The company was incorporated in 1995 and is headquartered in Abingdon, the United Kingdom.

Full EDNSF Calculator →

MRK — Healthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →

📬

Get this EDNSF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

EDNSF vs SCHD EDNSF vs JEPI EDNSF vs O EDNSF vs KO EDNSF vs MAIN EDNSF vs JNJ EDNSF vs ABBV EDNSF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.